Business
Aeterna Zentaris to Present at Upcoming BioFinance 2011 Conference in Toronto
May 25, 2011 (Canada NewsWire Group) -- QUÉBEC CITY, May 25, 2011 /CNW Telbec/ - Aeterna...
About this update from Cosciens Biopharma Inc.
[{"type":"text","content":"\n\n\n May 25, 2011 (Canada NewsWire Group) -- \n\n#ReleaseContent TABLE\n{\n BORDER-COLLAPSE: collapse\n}\nTR.cnwUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 1px solid\n}\nTR.cnwDoubleUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 3px double\n}\nTR.cnwBoldUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 3px solid\n}\nTD.cnwUnderlinedCell\n{\n BORDER-BOTTOM: #000000 1px solid\n}\nTD.cnwDoubleUnderlinedCell\n{\n BORDER-BOTTOM: #000000 3px double\n}\nTD.cnwBoldUnderlinedCell\n{\n BORDER-BOTTOM: #000000 3px solid\n}\n#ReleaseContent TABLE.cnwBorderedTable TD\n{\n BORDER-RIGHT: black 1px solid;\n PADDING-RIGHT: 2px;\n BORDER-TOP: black 1px solid;\n PADDING-LEFT: 2px;\n PADDING-BOTTOM: 2px;\n BORDER-LEFT: black 1px solid;\n PADDING-TOP: 2px;\n BORDER-BOTTOM: black 1px solid;\n BORDER-COLLAPSE: collapse\n}\n#ReleaseContent TABLE TD\n{\n PADDING-RIGHT: 2px;\n PADDING-LEFT: 2px;\n PADDING-BOTTOM: 2px;\n PADDING-TOP: 2px\n}\n\n\nQUÉBEC CITY, May 25, 2011 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ:\n AEZS) (TSX: AEZ) (the "Company") today announced that its Senior Vice\n President and CFO, Dennis Turpin, CA, will make a corporate\n presentation at the upcoming BioFinance 2011 Conference on Wednesday,\n June 1, 2011, at 10:00 a.m. (Eastern time) in Room 1 of the St.\n Andrew's Club & Conference Centre in Toronto, Canada.\n\n\nAbout Aeterna Zentaris Inc.\n\n\nAeterna Zentaris is a late-stage oncology drug development company\n currently investigating potential treatments for various cancers\n including colorectal, multiple myeloma, endometrial, ovarian, prostate\n and bladder cancer. The Company's innovative approach of "personalized\n medicine" means tailoring treatments to a patient's specific condition\n and to unmet medical needs. Aeterna Zentaris' deep pipeline is drawn\n from its proprietary discovery unit providing the Company with constant\n and long-term access to state-of-the-art therapeutic options. For more\n information please visit www.aezsinc.com.\n\n\n\n\n Investor Relations Ginette Vallières Investor Relations Coordinator (418) 652-8525 ext. 265 [email protected] Erika Moran The Investor Relations Group (212) 825-3210 [email protected] Media Relations Paul Burroughs Director of Communications (418) 652-8525 ext. 406 [email protected] \n\n","length":2767,"tagName":"...